PATENT CLAIM ANALYSIS

Application Number: 15886057
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["514", "210180"]

Abstract:
This invention relates to compounds that are agonists of the muscarinic M 1  receptor and/or M 4  receptor and which are useful in the treatment of muscarinic M 1 /M 4  receptor mediated diseases. Also provided are pharmaceutical compositions containing the compounds and the therapeutic uses of the compounds. Compounds include those according to formula (1a) or a salt thereof, wherein p, q, r, s, Q, R 3  and R 4  are as defined herein.

Claim (Index 25):
A compound of the formula (1): or a pharmaceutically acceptable salt thereof, wherein p is 1 or 2; q is 0, 1 or 2; r is 1 or 2; s is 0 or 1, where the total of r and s is 1 or 2; wherein the moiety: is selected from groups A to KKK as follows: and\n R 4  is a hydrogen or a C 1-6  non-aromatic hydrocarbon group which is optionally substituted with one to six fluorine atoms and wherein one or two, but not all, carbon atoms of the hydrocarbon group may optionally be replaced by a heteroatom selected from O, N and S and oxidised forms thereof.

Metadata:
- Claim Count in Document: 62.0
- Percentile: 88.0
- Lexical Diversity: 1.53571
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15699674', '15749743', '15227325', '15559375', '15117018']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.820019539039792
- 35 USC 102 Novelty (BERT): 0.5715178134026143
- Combined Prediction Score: 0.7951693664760743
- Mean Citation Score: 368.160338
- Max Citation Score: 470.58286
- Similarity Product: 389.2169138207364

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test